Related Experiment Videos
Renal cell carcinoma and normal kidney protein expression
C Sarto1, A Marocchi, J C Sanchez
1University Department of Clinical Pathology, Desio Hospital, Milan, Italy. sarto@desiolab.unimi.it
Electrophoresis
|March 1, 1997
Summary
This study identified two absent proteins, ubiquinol cytochrome c reductase (UQCR) and mitochondrial NADH-ubiquinone oxidoreductase complex I, in renal cell carcinoma (RCC) kidney tumors. These findings suggest mitochondrial dysfunction may play a key role in kidney cancer development.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Renal cell carcinoma (RCC) accounts for 3% of adult cancers, originating from kidney proximal tubular epithelium.
- Current diagnostic methods for RCC are insufficient for early detection, highlighting the need for novel biomarkers.
- Previous studies identified genetic alterations but lacked phenotypic markers for early diagnosis.
Purpose of the Study:
- To investigate protein expression differences between normal and tumor kidney tissues in RCC patients.
- To identify potential protein markers for early renal cell carcinoma diagnosis using advanced proteomic techniques.
- To explore the role of mitochondrial dysfunction in the genesis and progression of kidney cancer.
Main Methods:
- Utilized two-dimensional polyacrylamide gel electrophoresis (2-D PAGE) to analyze protein profiles of normal and RCC kidney tissues from ten patients.
- Established a human kidney protein map using the SWISS-2DPAGE database and ExPASy WWW Molecular Biology Server.
- Identified differentially expressed polypeptides through gel comparison, amino acid analysis, N-terminal sequencing, and immunodetection.
Main Results:
- Compared to normal kidney tissue, four polypeptides were found to be absent in RCC tissues.
- Two identified absent polypeptides were ubiquinol cytochrome c reductase (UQCR) and mitochondrial NADH-ubiquinone oxidoreductase complex I.
- The absence of UQCR and complex I suggests potential genetic alterations (deletions, transcription/translation changes) and points to mitochondrial dysfunction in RCC.
Conclusions:
- The absence of UQCR and mitochondrial NADH-ubiquinone oxidoreductase complex I in RCC indicates a significant role for mitochondrial dysfunction in kidney cancer.
- These findings may lead to the development of new diagnostic markers for early renal cell carcinoma detection.
- Further research into genetic alterations affecting these mitochondrial proteins is warranted to understand RCC pathogenesis.